Lumida
/LLY
⌘K
Eli Lilly and Co

Eli Lilly and Co

LLY
$1,115.70USD-0.65%-7.30 today

MARKET CAP

1.05T

P/E (TTM)

39.6x

FWD P/E

DAY RANGE

$1,113 – $1,131

52W RANGE

$712
$1,293

AI Summary

Stalk
Sell NowMedium

LLY is exhibiting a sequence of lower highs and lower lows under declining EMAs, reinforcing a bearish medium-term bias. Short-term trend remains down, with price rejecting rallies into the 9- and 20-day EMA zone despite extreme oversold readings. Execution is advised now on any bounce into the broken EMA region near the mid-$1,100s, with key invalidation being sustained acceptance above the 20-day EMA.

  • Q2 revenue $22.97B up 47.7% YoY, driven by Mounjaro and Zepbound
  • GLP-1 drugs make up ~65% of sales; Mounjaro surged 91% to $9.9B
  • Stretched valuation with low earnings yield and weak book-to-price metrics
Full analysis →

Buying

12

institutions

Selling

12

institutions

New Positions

2

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY67.54 M81.01 B+1.05 M+32.5%1.20%
JC

Jpmorgan Chase & Co

Q2 2026

SELL12.60 M15.50 B+-1.10 M+27.6%0.91%
JH

Janus Henderson Group Plc

Q1 2026

BUY8.69 M7.96 B+4.25 M+67.5%1.94%
CA

Citadel Advisors LLC

Q2 2026

BUY5.18 M6.21 B+1.63 M+90.4%0.71%
FA

Fisher Asset Management, LLC

Q2 2026

BUY5.06 M6.07 B+224.53 K+36.5%1.81%
CP

California Public Employees Retirement System

Q2 2026

SELL1.44 M1.73 B+-374.01 K+3.5%0.97%
AC

Aqr Capital Management LLC

Q2 2026

BUY1.04 M1.24 B+180.19 K+58.1%0.43%
MM

Millennium Management LLC

Q2 2026

SELL779.88 K935.41 M+-127.51 K+12.1%0.35%
GM

Grantham, Mayo, Van Otterloo & Co. LLC

Q2 2026

SELL743.97 K892.34 M+-5.85 K+29.4%2.01%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY559.34 K670.89 M+55.61 K+44.8%1.03%
MG

Man Group Plc

Q2 2026

SELL510.26 K612.02 M+-50.95 K+18.6%0.99%
WP

Woodline Partners LP

Q2 2026

SELL244.86 K293.69 M+-216.09 K-30.7%0.91%
BA

Balyasny Asset Management L.P.

Q2 2026

BUY223.55 K268.13 M+165.81 K+404.9%0.34%
BA

Bridgewater Associates, LP

Q2 2026

BUY87.02 K104.38 M+16.21 K+60.3%0.43%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY77.09 K92.47 M+59.98 K+487.3%0.70%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL76.88 K92.21 M+-80.79 K-36.4%0.10%
GC

Glenview Capital Management, LLC

Q2 2026

BUYNEW57.77 K69.29 M+57.77 K+0.0%1.26%
VI

Voloridge Investment Management, LLC

Q2 2026

SELL56.50 K67.77 M+-91.40 K-50.2%0.29%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

SELL50.48 K60.55 M+-976.07 K-93.6%0.04%
RT

Renaissance Technologies LLC

Q2 2026

SELL26.09 K31.29 M+-45.70 K-52.6%0.04%
EP

Eversept Partners, LP

Q2 2026

BUY20.12 K24.13 M+1.12 K+38.1%1.25%
DF

Duquesne Family Office LLC

Q2 2026

BUYNEW12.38 K14.85 M+12.38 K+0.0%0.28%
FC

Farallon Capital Management LLC

Q1 2026

SELL0.000.00+-375.00 K-100.0%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL0.000.00+-5.06 K-100.0%0.00%